Cite
HARVARD Citation
Tanaka, Y. et al. (2018). Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials. Modern rheumatology. 28 (4), pp. 583-591. [Online].